Title

Controversy around nevirapine trials continues

Document Type

Article

Department

Ophthalmology

Abstract

The US Institute of Medicine (IOM), commissioned by the National Institutes of Health (NIH) to review its HIVNET 012 clinical trial, is set to release its findings in March.

Publication

Lancet Infectious Diseases